Johnson & Johnson JNJ, a healthcare behemoth with a market cap exceeding $600 billion and a portfolio spanning pharmaceuticals and medical devices, has delivered a stellar year-to-date surge of ...

Johnson & Johnson JNJ will release its second-quarter earnings report before the opening bell on Wednesday, July 15. Analysts ...

Johnson & Johnson (JNJ) delivers Q2 earnings July 15. Wall Street projects $2.86 EPS, $25.02B revenue. See what analysts ...

The healthcare giant is making waves, but its true value for investors lies in how little it moves with the market.

This healthcare giant is on a serious run, but for investors arriving now, the question is whether the price of admission ...

The healthcare giant's second-quarter earnings will shine the spotlight on its exciting new products and pipeline.

Politicians serve on committees that set healthcare policy, monitor government contracts, and shape regulatory frameworks.

It can provide some stability during volatile times.

Eli Lilly (NYSE:LLY | LLY Price Prediction) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two ...

A sharp sector rotation has knocked down some of the market’s steadiest names, and Jim Cramer told CNBC viewers this week ...